AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/coms2/summary_0286-31945775_ITM" title="Facts and information about Thrombolytic agents (Systemic).">Thrombolytic agents (Systemic).</a>
Close
Set up an RSS feed that alerts you when new articles from USP DI-Volume II, Advice for the Patient: Drug Information in Lay Language are available.
Frequently asked questions about RSS feeds
Thrombolytic agents (Systemic).
Some commonly used brand names are:
In the U.S. --
Abbokinase (Urokinase (yoor-oh-KYE-nase))
Abbokinase Open-Cath (Urokinase (yoor-oh-KYE-nase))
Activase (Alteplase, Recombinant (AL-ti-plase))
Eminase (Anistreplase (an-EYE-strep-lase) (Not commercially
available in Canada.))
Kabikinase (Streptokinase (strep-toe-KYE-nase))
Streptase (Streptokinase (strep-toe-KYE-nase))
In Canada --
Abbokinase (Urokinase (yoor-oh-KYE-nase)) Abbokinase Open-Cath (Urokinase (yoor-oh-KYE-nase)) Activase rt-PA (Alteplase, Recombinant (AL-ti-plase)) Lysatec rt-PA (Alteplase, Recombinant (AL-ti-plase)) Streptase (Streptokinase (strep-toe-KYE-nase))
Other commonly used names are:
Anisoylated plasminogen-streptokinase activator
complex (Anistreplase (an-EYE-strep-lase) (Not commercially
available in Canada.))
APSAC (Anistreplase (an-EYE-strep-lase) (Not commercially
available in Canada.))
Tissue-type plasminogen activator (recombinant) (Alteplase,
Recombinant (AL-ti-plase))
t-PA (Alteplase, Recombinant (AL-ti-plase))
rt-PA (Alteplase, Recombinant (AL-ti-plase))
Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results
- Thrombolytic Agents (Systemic).
- USP DI-Volume II, Advice for the Patient: Drug Information in Lay Language July 28, 2005 700+ words
...activator (recombinant), t-PA...the following thrombolytic agents are numbered...Alteplase, Recombinant Anistreplase Reteplase, Recombinant Streptokinase...Description Thrombolytic agents are used to...
- Thrombolytic Agents (Systemic).(drug overview)(Drug overview)
- USP DI-Volume II, Advice for the Patient: Drug Information in Lay Language August 1, 2006 700+ words
...activator (recombinant), t-PA...the following thrombolytic agents are numbered...Alteplase, Recombinant Anistreplase Reteplase, Recombinant Streptokinase...Description Thrombolytic agents are used to...
- Thrombolytic Agents (Systemic).(Drug overview)
- USP DI-Volume II, Advice for the Patient: Drug Information in Lay Language May 1, 2006 700+ words
...activator (recombinant), t-PA...the following thrombolytic agents are numbered...Alteplase, Recombinant Anistreplase Reteplase, Recombinant Streptokinase...Description Thrombolytic agents are used to...
- Thrombolysis: newer thrombolytic agents and their role in clinical...
- Magazine article from: Heart Nordt, Thomas K. Bode, Christoph November 1, 2003 700+ words
...The most common thrombolytic agents have been streptokinase...third generation thrombolytic agents have reached clinical...RETEPLASE Reteplase (recombinant plasminogen activator...In the RAPID I (recombinant plasminogen activator...
- Thrombolytic agents no benefit to those over 75.(News)
- Magazine article from: British Medical Journal Gottlieb, Scott May 27, 2000 700+ words
Thrombolytic agents, currently promoted as the best emergency treatment for patients...the drugs. But in patients aged 75 and over, those getting thrombolytic agents were 40% more likely to die within 30 days of treatment (Circulation...
- Competitor Analysis: Thrombolytic Agents.
- Press release article from: M2 Presswire July 14, 2008 700+ words
...July 2008-Research and Markets: Competitor Analysis: Thrombolytic Agents(C)1994-2008 M2 COMMUNICATIONS LTD RDATE:14072008...announced the addition of the "Competitor Analysis: Thrombolytic Agents" report to their offering. Product description The present...
- Neuroprotective and thrombolytic agents: advances in stroke treatment.
- Magazine article from: Journal of Neuroscience Nursing Hock, Nanette June 1, 1998 700+ words
...pharmacologic interventions, both neuroprotective agents, which make the brain less susceptible to ischemia, and thrombolytic agents, which restore blood flow to the brain, are in the later stages of clinical development. The results from these...
- Intraoperative use of thrombolytic agents. (Editorial)
- Magazine article from: British Medical Journal Earnshaw, Jonothan J. Beard, Jonathan D. September 11, 1993 700+ words
...little alteration in coagulation, and bleeding is unusual even if fasciotomy is subsequently necessary. Other thrombolytic agents such as urokinase and tissue plasminogen activator may be used.[6 7] Lysis may be faster with tissue plasminogen...
- AngioDynamics (Queensbury, New York), a wholly owned subsidiary of E-Z-EM,...
- Newspaper article from: Cardiovascular Device Update May 1, 2004 700+ words
...worldwide market launch of the SpeedLyser Thrombolytic catheter, a catheter kit intended for the administration of thrombolytic agents into the peripheral vasculature. The SpeedLyser features slits to help evenly distribute the thrombolytic drug...
- AngioDynamics (Queensbury, New York), a wholly owned subsidiary of E-Z-EM,...
- Newspaper article from: The BBI Newsletter May 1, 2004 700+ words
...worldwide market launch of the Speed Lyser Thrombolytic catheter, a catheter kit intended for the administration of thrombolytic agents into the peripheral vasculature. The SpeedLyser thrombolytic catheter features slits to help evenly distribute...
